DAVITA INC. — Director's Dealing 2014

Jun 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-05-29

Reporting Person: Mildenberger Laura (Chief People Ofcr, Kidney Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-29	Common Stock	M	9375	$31.70	Acquired	16109	Direct
2014-05-29	Common Stock	F	4295	$69.20	Disposed	11814	Direct
2014-05-29	Common Stock	S	5080	$69.9861	Disposed	6734	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-29	Stock Appreciation Rights	$31.70	M	9375	Disposed	2015-03-31	Common Stock (9375)	Direct

Footnotes

F1: Represents the weighted average sale price of $69.9861. The range of prices for the sale of these shares was $69.92 - $70.09, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: Stock Appreciation Rights, granted on 3/31/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.